Evidence map›Paper›PMID 39273022›Full record

ArticleCells2024

Expression of

Zdenka Šitum Čeprnja, Nela Kelam, Marin Ogorevc, Anita Racetin, Martina Vukoja, Toni Čeprnja, Natalija Filipović, Mirna Saraga-Babić, Katarina Vukojević

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Spatial and Temporal Expression Patterns of EDA2R, PCDH9, and TRAF7 inInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zdenka Šitum ČeprnjaDepartment of Dermatovenerology, University Hospital of Split, 21000 Split, Croatia.
Nela KelamDepartment of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia.ORCID 0000-0002-6529-5474
Marin OgorevcDepartment of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia.ORCID 0000-0002-3801-1026
Anita RacetinDepartment of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia.
Martina VukojaLaboratory of Morphology, Department of Histology and Embryology, School of Medicine, University of Mostar, 88 000 Mostar, Bosnia and Herzegovina.
Toni ČeprnjaDepartment of Pathology, Forensic Medicine and Cytology, University Hospital of Split, 21000 Split, Croatia.
Natalija FilipovićDepartment of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia.ORCID 0000-0002-8943-4109
Mirna Saraga-BabićDepartment of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia.
Katarina VukojevićDepartment of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia.ORCID 0000-0003-2182-2890

Funding

Croatian Science Foundation IP-2022-10-8720
6 · The paper itself

Abstract

Melanoma is the most severe type of skin cancer and among the most malignant neoplasms in humans. With the growing incidence of melanoma, increased numbers of therapeutic options, and the potential to target specific proteins, understanding the basic mechanisms underlying the disease's progression and resistance to treatment has never been more important. LOXL3, SNAI1, and NES are key factors in melanoma genesis, regulating tumor growth, metastasis, and cellular differentiation. In our study, we explored the potential role of LOXL3, SNAI1, and NES in melanoma progression and metastasis among patients with dysplastic nevi, melanoma in situ, and

Indexed as

Disease ProgressionMelanomaSnail Family Transcription FactorsAmino Acid OxidoreductasesCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedNeoplasm MetastasisSkin NeoplasmsAmino Acid OxidoreductasesSNAI1 protein, humanSnail Family Transcription FactorsBRAFdysplastic nevusLOXL3melanomaNESSNAI1

Identifiers

PMID39273022
PMCPMC11394338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.